Jane Street’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.26M Sell
246,199
-9,893
-4% -$171K ﹤0.01% 1455
2025
Q1
$5.6M Buy
256,092
+160,107
+167% +$3.5M ﹤0.01% 1274
2024
Q4
$3.06M Buy
95,985
+76,705
+398% +$2.45M ﹤0.01% 1621
2024
Q3
$556K Sell
19,280
-181,609
-90% -$5.24M ﹤0.01% 4169
2024
Q2
$7.71M Buy
200,889
+71,880
+56% +$2.76M ﹤0.01% 1260
2024
Q1
$7.58M Sell
129,009
-305,692
-70% -$18M ﹤0.01% 982
2023
Q4
$26M Buy
434,701
+161,475
+59% +$9.67M 0.01% 435
2023
Q3
$10.4M Sell
273,226
-207,856
-43% -$7.91M ﹤0.01% 809
2023
Q2
$43.8M Buy
481,082
+417,698
+659% +$38.1M 0.01% 271
2023
Q1
$4.18M Buy
63,384
+49,363
+352% +$3.26M ﹤0.01% 1343
2022
Q4
$725K Sell
14,021
-2,977
-18% -$154K ﹤0.01% 3001
2022
Q3
$1.16M Sell
16,998
-77,584
-82% -$5.3M ﹤0.01% 2634
2022
Q2
$4.28M Buy
94,582
+19,472
+26% +$881K ﹤0.01% 1233
2022
Q1
$3.82M Sell
75,110
-25,601
-25% -$1.3M ﹤0.01% 1442
2021
Q4
$4.76M Buy
100,711
+84,768
+532% +$4.01M ﹤0.01% 1118
2021
Q3
$525K Sell
15,943
-18,619
-54% -$613K ﹤0.01% 3376
2021
Q2
$2.18M Buy
34,562
+11,464
+50% +$724K ﹤0.01% 1683
2021
Q1
$991K Sell
23,098
-33,854
-59% -$1.45M ﹤0.01% 2518
2020
Q4
$3.26M Buy
56,952
+14,382
+34% +$823K ﹤0.01% 1017
2020
Q3
$1.28M Buy
42,570
+19,591
+85% +$591K ﹤0.01% 1558
2020
Q2
$750K Buy
+22,979
New +$750K ﹤0.01% 2194
2020
Q1
Sell
-8,135
Closed -$249K 3389
2019
Q4
$249K Sell
8,135
-87,589
-92% -$2.68M ﹤0.01% 2844
2019
Q3
$2.31M Buy
95,724
+82,285
+612% +$1.98M ﹤0.01% 837
2019
Q2
$341K Buy
+13,439
New +$341K ﹤0.01% 2623